Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in March 2026
NEWARK, CA / ACCESS Newswire / February 24, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that...
NEWARK, CA / ACCESS Newswire / February 24, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that...
LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national...
Dr. Drew Brown IV, a Tampa, Florida, orthopedic spine surgeon and founder of DB4Spine, is promoting a simple personal standard...
CARLSBAD, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will...
Company Highlights Advanced Partnering Discussions as AD04 Advances Toward Phase 3GLEN ALLEN, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Adial...
MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD),...
Initial 13-site deployment with UK subsidiary of global construction firm employing 35,600 employees across 50+ countries, validates commercial scalability and...
CHICAGO and FORT WORTH, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”),...
Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full analysis...
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 24, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the...
Technology supports the evolution of enteral access from blind procedures to real-time visualized placementTYLER, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE)...
GLP-1 drugs have captured global attention, but they come with limitations — tolerability issues, muscle mass loss, and potential cardiovascular...
Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite...
Early Post-Clearance Momentum Signals Accelerated Hospital Adoption of Advanced RoboticsHINGHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc....
CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of...
First Wave of Influencers with Combined Reach of Over 23 Million to Drive National AwarenessLake Oswego, Oregon--(Newsfile Corp. - February...
CUMMING, Ga., Feb. 24, 2026 /PRNewswire/ -- HomeTown Health University (HTHU) (www.hthu.net | https://lms.hthu.net) has been providing healthcare professional development...
Recognizing visionary leadership in sustainable energy, the awards spotlight women scientists transforming communities in lower-income countriesAMSTERDAM, Feb. 24, 2026 /PRNewswire/...
NEW YORK, Feb. 24, 2026 /PRNewswire/ -- disAMR, a new company formed by partners who built Brammer Bio and have worked...
Collaboration combines Kyndryl's AI Innovation Lab and Kyndryl Consult AI expertise with the University of Liverpool's Civic Health Innovation Labs...